Drug profile · INN
anakinra
KINERET
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
anakinra (KINERET) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN anakinra
Brand KINERET
Route SUBCUTANEOUS
Formulation VIAL
ATC code L04AC03
Frequently asked questions
What is anakinra?
anakinra (KINERET) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for anakinra?
KINERET is a marketed brand name for anakinra. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of anakinra?
anakinra has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.